Abbott Opens Fire On J&J Unit Over Humira Patent

Law360, New York (May 4, 2009, 12:00 AM EDT) -- Abbott Biotechnology Ltd. has filed a suit alleging a Johnson & Johnson unit's newly approved drug infringes Abbott's patent for the blockbuster rheumatoid arthritis medication Humira.

In a declaratory judgment suit filed Friday in the U.S. District Court for the District of Massachusetts, Abbott alleges that Centocor Ortho Biotech Inc.'s Simponi infringes its patent for Humira.

Brian Kenney, a representative of Centocor, denied the allegations Monday. “We are currently reviewing the complaint and will vigorously contest it. We believe we have rights to all of the...
To view the full article, register now.